1Managing paediatric acute severe ulcerative colitis according to the 2011 ECCO-ESPGHAN guidelines: Efficacy of infliximab as a rescue therapyDigestive and Liver Diseases  Clinical Article
2High treatment modification rates with lamivudine therapy in HBV infected patients with low baseline viremia and early virologic response: A multicenter studyJournal of Digestive Diseases  Clinical Article
3Risk of microangiopathy in type 2 diabetes mellitus patients with or without chronic hepatitis C: Results of a retrospective long-term controlled cohort studyDigestive and Liver Diseases  Clinical Article
4Prospective, comparative effectiveness trial of cows milk elimination and swallowed fluticasone for pediatric eosinophilic esophagitisDiseases of the Esophagus  Clinical Article
5Azithromycin in early infancy and pyloric stenosisPediatrics  Clinical Article
6Oxidative balance scores and risk of incident colorectal cancer in a US prospective cohort studyAmerican Journal of Epidemiology  Clinical Article
7A case study of a hepatitis B screening and blood pressure assesment program in Los Angeles County, 2012–2013Preventing Chronic Disease  Full Text  Review Article
8The impact of human papillomavirus infection on the survival and treatment response of patients with esophageal cancersJournal of Digestive Diseases  Clinical Article
9Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinomaJournal of Hepatology  Clinical Article
10Response of serum alpha-fetoprotein to entecavir therapy predicts risk for hepatocellular carcinoma in patients with chronic hepatitis BJournal of Gastroenterology and Hepatology  Clinical Article
1Standardization and simplification is key to helping NICU babies feed and growNationwide Children's Hospital
2Published outcomes announced from study on adolescent bariatric surgery safetyNationwide Children's Hospital
3New study details burden of C. diff in U.S.University of Rochester Medical Center
4Reducing disparities in colon cancer through integrated careKaiser Permanente Health Research News
5Use of new systemic adjuvant therapy in gastrointestinal tumors (GITSs) increasing, leading to better survivalAmerican Cancer Society News
6Daclatasvir for hepatitis C: Hint of added benefit in genotype 4German Institute for Quality and Efficiency in Health Care (IQWiG)
7In lab research, SLU team halts NASH liver damageSaint Louis University Health News
8QMUL and Takeda announce research collaboration to develop new therapies in gastroenterologyQueen Mary University of London News
9Researchers find link between inflammation, tissue regeneration and wound repair responseUC San Diego Health System
10Crohn's disease not exempt from racial disparitiesNationwide Children's Hospital

Show Me:

Risk factors for intra-abdominal abscesses in Crohn’s disease

As reported in Digestion, uncontrolled CRP at week 14 of therapy with infliximab (OR=1.36) and early loss of response to infliximab (OR=5.36) are independent risk factors for intra-abdominal abscesses in patients with Crohn’s disease.

KIT mutations associated with poor prognosis in GISTs

Based on a meta-analysis (18 studies; n=1487) reported in the World Journal of Surgical Oncology, KIT mutations in patients with gastrointestinal stromal tumors (GISTs) are associated with larger tumors (> 5 cm), higher mitotic activity (> 5), more frequent recurrences (OR = 2.06), more frequent metastases (OR = 2.77), and worse 3-year overall survival (OR = 0.47) compared to patients with PDGFRA mutations or wild-type.

SCCA-IgM predicts survival in HCC patients

As reported in the Journal of Gastroenterology & Hepatology, SCCA-IgM levels are elevated in patients with hepatocellular carcinoma (HCC) compared to patients with cirrhosis and healthy controls. Not only does the SCCA-IgM level predict overall and progression-free survival in HCC patients, but the sensitivity of SCCA-IgM in patients with HCC was 2-fold greater than AFP. A decline in SCCA-IgM levels was shown to be associated with response to treatment.

Are YOU the Smartest Doc in America?

The Smartest Doc from MDLinx keeps you current with a competitive edge, pitting colleagues against one other for the title of The Smartest Doc in America.

Take the Challenge

Clinical Pearls

Clinical Pearl from Smartest DocDisease and treatment characteristics predict survival associated with Yttrium-90 radioembolization for colorectal carcinoma hepatic metastases.

Clinical Pearl from Smartest DocPreoperative bile replacement is useful for improving blood coagulability and cellular immunity in jaundiced patients with external biliary drainage.

Clinical Pearl from Smartest DocExamining the relationship transient lower esophageal sphincter relaxations and gastric accommodation may provide insight into GERD pathology.

The Top Read Articles of 2014 are Now Available

Scouring thousands of peer-reviewed journals and popular press, Our Editors just released the Top Read Articles of the Year. See the Top Read List